
Published On: Oct 2023
Published On: Oct 2023
According to Business Market Insights research, the North America decapping system market was valued at US$ 137.19 million in 2022 and is expected to reach US$ 184.42 million by 2028, registering a CAGR of 5.1% from 2022 to 2028. Accelerated demand for vaccine egg decapper in process industry and innovative product launches are the critical factors attributed to the North America decapping system market expansion.
Medical device companies focus on developing and launching new products and obtaining approvals from corresponding regulatory bodies. A few of the recent developments in the North America decapping system market are mentioned below: In July 2022, Rhinostics and Azenta Life Sciences announced a new product launch of "RHINOstic Automated Swab and IntelliXcap Automated Screw Cap Decapper/Recapper 96-format" through a joint venture. By using Azenta's decapper technology, the laboratories can benefit from an instantly scalable automated swab processing workflow. Also, the IntelliXcap, in combination with RHINOstic Automated Swab, increases output by decreasing the turnaround times with per-test cost for laboratories using swab collection for COVID-19, multi-analyte respiratory panels, sexually transmitted diseases, and genetic testing. In February 2022, Hamilton Company announced the launch of a new product, "LabElite Handheld DeCapper," providing a rapid and repeatable decapping and capping of 48 and 96-format racked tubes. The new product is a semi-automated device that bridges the gap between manual and fully automated sample decapping tasks intended for significant efficiencies with less physical strain. Therefore, increasing product developments, launches, and approvals by the market players are accelerating the North America decapping system market expansion.
On the contrary, technical errors and repetitive manual tasks associated with dapping system hampers the North America Decapping System Market.
Based on type, the North America decapping system market is segmented into manual, semi-automated, and automated. The automated segment held 61.4% share of North America decapping system market in 2022, amassing US$ 84.19 million. It is projected to garner US$ 116.62 million by 2028 to expand at 5.6% CAGR during 2022–2028.
Based on application, the North America decapping system market is segmented into tubes and vials. The tubes segment held 85.8% share of North America decapping system market in 2022, amassing US$ 117.69 million. It is projected to garner US$ 158.52 million by 2028 to expand at 5.1% CAGR during 2022–2028.
Based on end user, the North America decapping system market is segmented into pharmaceutical and biotech industry, CDMOs/CROs, and others. The pharmaceutical and biotech industry segment held 65.9% share of North America decapping system market in 2022, amassing US$ 90.34 million. It is projected to garner US$ 120.96 million by 2028 to expand at 5.2% CAGR during 2022–2028.
Based on country, the North America decapping system market is segmented into the US, Canada, and Mexico. Our regional analysis states that the US captured 82.2% share of North America decapping system market in 2022. It was assessed at US$ 112.83 million in 2022 and is likely to hit US$ 151.72 million by 2028, exhibiting a CAGR of 5.1% during 2022–2028.
Key players operating in the North America decapping system market are Agilent Technologies Inc, Azenta Inc, Cole-Parmer Instrument Co LLC, Hamilton Co, Micronic Holding BV, Sarstedt AG & Co KG, and Thermo Fisher Scientific Inc, among others.
Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com